Reuters: Aspirin's benefit in preventing colon cancer depends on DNA

NEW YORK (Reuters) - Cancer is the first disease where physicians have personalized treatment, matching a tumor's genetics to the appropriate chemotherapy, and now it may be the first in which prevention, too, can be personalized. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/Lz6CaetdRA4/story01.htm

Read More